Cervical cancer is a malignant disease of the epithelial cells of the endocervix or exocervix. It is undeniably linked to Human Papilloma Virus infection. It is the fourth most common malignant disease in women in the world, while in Croatia it ranks 21st. Developed countries are witnessing a decline in the incidence of the cervical cancer, but the disease remains a burden on the health system of developing countries. Until 2018 the assessment of disease progression was based mostly on data obtained from clinical examination. However, magnetic resonance imaging, due to its ability to distinguish soft tissue, has been included in the staging protocol. Numerous studies have compared current practice of clinical staging and staging based on magnetic resonance imaging. It was found that magnetic resonance imaging provides more accurate data on disease progress on the basis of which it is possible to optimize further treatment plan. Magnetic resonance imaging is indicated when setting stage IB or higher, in case of preoperative work-up of patients candidates for sparing surgery, and is also used in protocol of monitoring the response to therapy and possible recurrence of the disease. On T2-weighted sequences, cervical cancer appears as a mass of medium to high signal intensity. The disadvantage of conventional magnetic resonance imaging is the inability to determine tumor aggressiveness and analyze the tumor microenvironment. DWI and DCE methods are being increasingly used for planning an optimal therapy and evaluating its success.